title: Therapy with direct-acting antivirals for genotype 3 patients: interferon's last gasp?
authors.affiliation: Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: resteban@vhebron.net.
authors.forename: Rafael
authors.initials: R
authors.lastname: Esteban
authors.affiliation: Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: Maria
authors.initials: M
authors.lastname: Buti
mesh_terms: D001562:Benzimidazoles / Q000627:therapeutic use*; D005260:Female; D005449:Fluorenes / Q000627:therapeutic use*; D016174:Hepacivirus / Q000187:drug effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D012367:RNA, Viral / Q000187:drug effects*; D012254:Ribavirin / Q000627:therapeutic use*; D000069474:Sofosbuvir / Q000627:therapeutic use*
chemical_list: D001562:Benzimidazoles; D005449:Fluorenes; D016898:Interferon-alpha; D012367:RNA, Viral; D012254:Ribavirin; D000069474:Sofosbuvir